BIO-VIN ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  8.9% 3.8% 3.0% 4.1% 2.8%  
Credit score (0-100)  29 51 56 49 59  
Credit rating  BB BBB BBB BBB BBB  
Credit limit (kDKK)  -0.0 -0.0 -0.0 -0.0 -0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  -460 47.6 310 313 336  
EBITDA  -547 -19.2 188 69.4 155  
EBIT  -613 -84.7 122 3.2 85.5  
Pre-tax profit (PTP)  -701.8 -129.1 192.5 54.5 51.4  
Net earnings  -233.8 -129.1 192.5 54.5 51.4  
Pre-tax profit without non-rec. items  -702 -129 192 54.5 51.4  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  4,230 4,164 4,099 4,074 4,004  
Shareholders equity total  -3,972 -4,101 -3,908 -3,854 -3,802  
Interest-bearing liabilities  3,156 2,544 2,569 2,536 2,299  
Balance sheet total (assets)  5,189 5,112 5,101 5,050 4,944  

Net Debt  3,151 2,473 2,564 2,533 2,289  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  -460 47.6 310 313 336  
Gross profit growth  -25.4% 0.0% 551.3% 0.8% 7.5%  
Employees  0 0 0   1  
Employee growth %  0.0% 0.0% 0.0% 0.0% 9,900.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  5,189 5,112 5,101 5,050 4,944  
Balance sheet change%  220.6% -1.5% -0.2% -1.0% -2.1%  
Added value  -547.5 -19.2 187.9 68.7 155.1  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  4,164 -131 -131 -91 -139  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  -4.0 -5.0 1.0 2.0 3.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  133.2% -177.9% 39.5% 1.0% 25.5%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  -7.4% -0.1% 3.0% 1.8% 2.4%  
ROI %  -7.8% -0.2% 3.4% 2.0% 2.5%  
ROE %  -6.9% -2.5% 3.8% 1.1% 1.0%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  -43.4% -44.5% -43.4% -43.3% -43.5%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -575.6% -12,888.4% 1,364.9% 3,650.2% 1,475.8%  
Gearing %  -79.5% -62.0% -65.7% -65.8% -60.5%  
Net interest  0 0 0 0 0  
Financing costs %  9.3% 4.1% 3.3% 4.1% 6.6%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  0.1 0.2 0.1 0.1 0.2  
Current Ratio  0.4 0.4 0.3 0.2 0.4  
Cash and cash equivalent  4.4 71.2 4.7 3.2 10.2  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -816.1 -753.8 -1,070.8 -1,145.8 -463.2  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 6,870 155  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 6,938 155  
EBIT / employee  0 0 0 323 86  
Net earnings / employee  0 0 0 5,455 51